













PERINATAL OUTCOME IN MOTHERS WITH HEART 
DISEASE ATTENDING THE COMBINED OBSTETRIC 

































The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
 
Published by the University of Cape Town (UCT) in terms 





























Correspondence Address      
 
PO Box 43908       
Fish Hoek         
7974 
         
 
 
















ABSTRACT           4 
INTRODUCTION         5 
OBJECTIVES          14 
METHODS          15 
Definitions         16 
Data Collection        19 
Ethics Approval        19 
Data Analysis          19 
RESULTS          17 
DISCUSSION          31 
CONCLUSION          34 
APPENDICES         35 






















With the advances made in the management of cardiac conditions, much importance 
has been placed on the maternal outcome in pregnancies complicated by heart 
disease. However, to enable attending clinicians to provide suitable counseling and 
manage the pregnancy appropriately, the potential complications arising in the fetus 
and neonate also require attention. Adverse neonatal and perinatal outcome is more 
common in pregnant women with cardiac disease. Analysis of the available data 
pertaining to the South African population is important, as this population’s profile, 
like that of Africa, differs from that of industrialized countries. The relevance of 
maternal heart disease is highlighted by the National Committee for the Confidential 





To describe the perinatal outcome in women with heart disease and to determine 
whether there is an associated adverse outcome related to babies born to mothers 
with heart disease. 
 
Methods 
82 patients were collected serially over 18 months. Neonatal outcome was recorded.  
Adverse neonatal outcome was defined as perinatal mortality, admission to NICU 
and the need for delivery room resuscitation.  
 
Results 
Perinatal mortality rate in this cohort was good, and better than the rate in the 
general population from whence this cohort came, but was linked to a high rate of 
obstetric intervention. The rate of adverse neonatal outcome is better than the rate in 
industrialized countries.  
 
Conclusion 
Perinatal outcome is good when mothers with heart disease are managed in a 







With the advances made in the management of cardiac conditions, much importance 
has been placed on the maternal outcome in pregnancies complicated by maternal 
heart disease. However, to enable attending clinicians to provide suitable counseling 
and manage the pregnancy appropriately, the potential complications arising in the 
fetus and neonate also require attention.  
 
Previous published literature has shown that a detailed risk analysis allows for 
improved management during pregnancy and can serve to predict both maternal and 
neonatal morbidity.1 Such assessments will enable clinicians to determine the level of 
surveillance required and allow for informed decisions prior to conception, throughout 
the pregnancy and in the postpartum period.2   
 
Global perspective  
Pregnancy in the presence of maternal heart disease remains an important topic for 
interrogation worldwide. Although mortality from heart disease in pregnancy is low in 
absolute terms, it remains the leading cause of indirect maternal mortality in 
developed countries,1,3-8 whilst in developing countries it remains one of the major 
indirect causes of maternal death, prompting continuous efforts to improve 
screening, diagnosis and management of heart disease.  
 
The aetiology of cardiac disease can either be congenital or acquired. Many 
congenital lesions are described and the prognosis for each may differ, depending on 
the structural changes within the heart and the progression of the disease.  
 
In developed countries congenital heart disease (CHD) is the most prevalent form of 
cardiac disease in pregnancy. Due to advances in diagnosis and surgical intervention 
in infancy and childhood, most women with CHD reach childbearing age. In Europe, 
CHD makes up 80% of all heart disease in pregnant patients.1  
 
The reduction in the number of maternal deaths, as well as the risk of maternal death 
in pregnancies complicated by heart disease in developed countries over recent 
years, is largely due to the advancement of interventions and corrective surgery for 





The nature of the presenting lesion, the effect of the lesion on cardiac function and 
other maternal characteristics, can predict the maternal outcome of cardiac disease 
during pregnancy. If the mother enters pregnancy with normal cardiac function, the 
risk of adverse outcome is less. The World Health Organization (WHO) has classified 
maternal disease into four categories. In this classification, category I has very little 
effect on the outcome of pregnancy, while category IV is considered a 
contraindication to pregnancy.9  
 
African perspective 
In developing countries the prevalence of disease differs significantly from that of 
developed countries. Congenital heart disease remains prevalent. However, the 
largest component of maternal cardiac disease in Southern Africa is valvular disease 
secondary to rheumatic fever. The incidence of rheumatic heart disease is estimated 
at 13 cases per 100 000 per year.1,10  
 
Rheumatic valvular heart disease may involve any of the heart valves, however, 
mitral stenosis is by far the most common presentation,10 and carries the greatest 
risk.11 Mitral stenosis may not be well tolerated in pregnancy and the presence of 
maternal mitral stenosis has been described an independent predictor of maternal 
mortality.10 Pregnant women with valvular heart disease have a statistically 
significant risk of cardiac events, clinical deterioration and adverse neonatal 
outcome.12  Valvular heart disease is sometimes first diagnosed in pregnancy, 







South African perspective  
Analysis of the available data pertaining to the South African population is important, 
as this population’s profile, like that of Africa, differs from that of industrialized 
countries cited in the literature. The relevance of maternal heart disease is 
highlighted by the National Committee for the Confidential Enquiries into Maternal 
Deaths in South Africa. (http://www.doh.gov.za/docs/reports/2012/Report_on_ 
Confidential_Enquiries_ into_Maternal_ Deaths_in_South_Africa). “Medical disorders 
in pregnancy”, are grouped together as one of the top five causes for maternal 
mortality in South Africa. Within this category, cardiac disease is the most prevalent 
disorder. Further enquiry into the causes and consequences of heart disease in 
pregnancy occurring in South African women is necessary in order to improve the 
clinical outcome. In particular, the analysis of maternal heart disease should focus on 
severe maternal morbidity as this has been linked to poor perinatal outcome. The risk 
of a maternal cardiac event or the development of complications can be predicted by 
assessing baseline criteria of the mother prior to pregnancy and also at the time of 
the booking visit.5,9  
 
The physiological changes in pregnancy 
The physiological adaptions in pregnancy, designed to support the pregnancy and 
placental perfusion include circulatory adaptions. These are usually well tolerated in 
pregnancy, but may adversely affect cardiac function in the presence of heart 
disease.  
 
The central adaption is peripheral vasodilatation with a decrease in peripheral 
vascular resistance. Following this, the cardiac output increases by about 40-50% 
mostly due to an increase in stroke volume and secondly due to an increase in the 
heart rate (10- 20 beats per minute) from about 60 bpm to 80 bpm.13 The blood 
pressure will decrease due to the drop in peripheral vascular resistance. There is a 
40-50% increase in blood volume and another 50% increase at delivery when there 
is an auto-transfusion of blood from the contracting uterus into the general 
circulation.14 These changes can occur as early as the first trimester, and usually 
return to baseline by 6 weeks postpartum.15 
 
The normal heart can tolerate these changes well, and pregnancies remain 
uncomplicated, however in the case of heart disease, be it structural or functional, 
the circulatory system may be compromised. The stressors placed on the heart may 




decrease in cardiac output will reduce placental perfusion and result in potential fetal 
hypoxemia. 
 
Neonatal outcome  
Adverse neonatal and perinatal outcome is more common in pregnant women with 
cardiac disease - even when demographic and obstetric risk factors have been 
accounted for - and is partly related to maternal cardiac disease.1,2,4  
 
The frequency of neonatal complications can be up to twice that of the control group 
and for each individual complication the risk is higher in the maternal heart disease 
group. The rate of occurrence of neonatal complications is 17-28%.2,5  There is a 
clear relationship between the severity of the cardiac disease and fetal 
complications.1,5  
 
Perinatal outcome can be measured in terms perinatal complications associated with 
maternal cardiac disease, and these include: premature delivery, (PTD) (prior to 37 
completed weeks gestation,) respiratory distress syndrome (RDS), birth asphyxia, 
intrauterine growth restriction (IUGR), the delivery of babies small for gestational age 
(SGA) (with birth weight below 3rd percentile), intraventricular haemorrhage (IVH), 
early neonatal death (ENND) and stillbirth (SB) as well as inherited congenital 
cardiac lesions and those complications associated with maternal medication such 
as embryopathy (in the case of warfarin use).2,3  
 
The perinatal mortality rate (stillbirths and early neonatal deaths) is between 1 – 4%.4 
This rate was significantly higher than the background population (1%) This may well 
be accounted for by the high rate of PTD in this group of patients resulting in more 
early neonatal deaths. 
 
In sub-Saharan Africa the perinatal mortality rate associated with maternal cardiac 
disease is quoted as 7.6 %.11 In this region adverse maternal and neonatal outcome 
appears to be significantly higher - almost double the rate reported by industrialized 
countries. The most significant cause for perinatal mortality in sub-Saharan Africa is 
preterm birth3 with 16% of these deliveries occurring before 34 weeks.1,4,5   
 
This is higher than the general background prematurity rate reported in the literature 
(10%). Iatrogenic preterm delivery may account for this increase because preterm 




disease. PTD rates are generally higher, the more complex the cardiac disease. In 
the case of CHD, PTD may occur in 22% of women with cyanotic disease and 65% 
in Eisenmenger syndrome. In these CHD lesions where PTD was reported to be 
higher, the perinatal mortality rate increased and in Eisenmenger syndrome it has 
been quoted as being as high as 27.7%.4 The sequaele of PTD include RDS, 
pulmonary haemorrhage and IVH.5 
 
Obstetric complications are specifically linked to certain cardiac disease. Coarctation 
of the aorta, pulmonary stenosis or transposition of the great arteries, have a higher 
risk of developing preeclampsia, which places the fetus at risk of IUGR, SB and 
iatrogenic preterm delivery.4,16 
 
While there is agreement that cardiac disease in the mother places the fetus and 
neonate at greater risk than low risk pregnancies, it is important to consider also the 
likelihood of the pregnancy being successful.4 The association between maternal 
cardiac disease and adverse perinatal outcome is highly correlated, and therefore, 
correct assessment of the maternal risk is necessary in order to provide increased 
surveillance where indicated. The literature has provided risk analysis frameworks for 
the assessment of maternal condition. These include the following maternal 
predictors of adverse neonatal outcome (Table 1). 
 
Table 1: Maternal predictors of adverse perinatal outcome 
Baseline NYHA >II or cyanosis 
Maternal left heart obstruction  
Smoking during pregnancy 
Multiple gestation 
Use of oral anticoagulants 
Mechanical valve prosthesis 
Symptomatic arrhythmia 
 
Reasons for the increased rate of neonatal complications associated with the cited 
maternal risk factors vary. 
 
NYHA >II and cyanosis at booking are independent risk factors for neonatal 
complications.5 Fetal cardiac output is adversely affected by fetal hypoxemia 




cardiac output or impaired oxygenation. For each percentage drop in maternal 
saturation reading, the risk to the fetus increases.2 Maternal cyanosis similarly leads 
to IUGR, PTD and SB.2,4,17 
 
There is also an increase in the risk of miscarriage to mothers with cyanotic lesions 
and/or those with poor NYHA functional class.5 Maternal left heart obstruction can be 
quantified as a sub-aortic ventricular outflow gradient of >30mmHg.2,3,5,9  
 
Even a moderate degree of mitral stenosis will have an adverse effect on the 
pregnancy as indicated in Table 1.1 
 
Hameed et al reported that more than half the patients with moderate or severe 
valvular heart disease suffered some cardiac event with left heart obstruction 
common among this group of patients.12 
.  
They were especially at risk of CCF and arrhythmias. These complications led to a 
greater risk of PTD or the delivery of a neonate with signs of IUGR.12 
 
Even events prior to pregnancy, such as arrhythmias, may increase the risk to the 
fetus and neonate.5  
 
In addition, the effect of many cardiovascular drugs, for example β-blockers, have 
been shown to be related to an IUGR and prematurity.12 
 
Smoking in these patients can add additional risk, although the mechanisms behind 
this are not fully understood. It may be that the advice to cease smoking may be 
even more critical in the management of these women. One surprising finding was 
that pulmonary HT was not associated with any fetal complications during 
pregnancy.5 
 
The Addition of Obstetric Risk Factors  
If none of the above risk criteria pertain, and there are no obstetric risk factors, the 
risk of adverse perinatal outcome remains very close to that of controls (about 4% in 
controls and 5% in cardiac patients). However, the potential adverse effect of 
maternal cardiac disease on neonatal outcome is amplified if there are concurrent 





Early pregnancy loss 
The rate of abortion (spontaneous or induced) has been reported to be as high as 
20%.3 
 
This figure is not significantly different to that of the general population. Although 
Drenthen et al described a miscarriage rate to be higher in patients with cyanosis 
(such as in the case of pulmonary atresia with VSD). The miscarriage rate in patients 
with Eisenmenger Syndrome was just over 10%, which is similar to that of a patient 
with an ASD or VSD. This is lower than the background rate of spontaneous 
miscarriage in the general population, which is estimated to be between 15-30%. 
Hence cardiac disease is not associated with an increased risk of miscarriage.4 
 
Inheritance  
Heritable factors may contribute to adverse perinatal outcome in women with cardiac 
disease.  
 
In the general population the risk of a congenital cardiac abnormality is 1%. 
However, the risk to a fetus born to parents with CHD depends on whether the CHD 
is present in the mother or father or both parents. Generally the risk is slightly higher 
if the lesion is on the maternal side. Furthermore, the risk of inheritance (3-50%) 
depends on the type of lesion. A lesion associated with a condition such as Marfan’s 
syndrome - which has an autosomal dominant pattern of inheritance - carries a risk 
of 50%. However, the final phenotype depends on the penetrance.  Samuel et al and 
Khairy et al, describe the rate of congenital heart lesions found in offspring born to 
parents with CHD as approximately 7%. Drenthen et al describe an incidence of 0.6-
8% depending on the type of lesion.3,4,17 
 
Some cardiac lesions carry a far greater heritable trait as they are linked to certain 
genes. These lesions include coarctation of the aorta and a bicuspid aortic valve, 
which are highly heritable. Truncus arteriosus such as found in Di George syndrome 
(deletion of 22q11.2) follows an autosomal recessive pattern. ASD and VSD can be 
isolated lesions but can also be linked to genetic disorders including Holt-Oram, 
Towes-Brocks and other chromosomal abnormalities.18  
 
Cardiac patients should be screened with a nuchal translucency (NT) scan: The risk 
of CHD in the presence of a normal NT is 1/1000 and the sensitivity of NT screening 




women with lesions related to a syndrome by means of chromosomal analysis. Direct 
examination of the fetal heart takes place at 22 weeks when visualization of the heart 
and outflow tracts is possible.  
 
Fetuses affected by CHD may be at risk of brain injury secondary to changes in fetal 
blood flow caused by the structural abnormalities of the heart. The blood flow in the 
fetus preferentially selects the passage of oxygen and nutrients from placenta to the 
fetal brain and structural defects in the heart associated with CHD may well impair 
this mechanism. In these cases the fetus may auto-regulate cerebral vascular 
resistance to increase cerebral flow. There is also an epidemiological association 
between complex CHD and babies born with small head sizes and IUGR. 
Postmortem examinations of  fetuses who did not survive and ultrasound of the 
cranium of those neonates born with CHD have shown instances of cerebral atrophy 
and IVH.19 
 
Long-term outcome  
An association between neonatal complications and cognitive and 
neurodevelopmental delay has been demonstrated. This should be disclosed to the 
patient at the preconception visit and during subsequent antenatal care.  
 
The study proposal and research question 
The care of pregnant patients with cardiac disease requires special attention to be 
paid to accurate diagnosis, treatment and management throughout the pregnancy. 
This can only be achieved once an accurate assessment of the potential maternal 
and fetal complications has been made. Counseling is aimed at addressing the risks 
involved with pregnancy and delivery, and includes future cardiac function, the risk of 
shortened life expectancy, decreased quality of life, and the implications for the baby 
and future fertility. The assessment of risk and detailed counseling has been based 
on the available literature from industrialized countries which has been extrapolated 
to a South African patient population. Data unique to a South African population are 
few; clinical circumstance and co-morbidity may therefore remain undisclosed.  
 
A registry of pregnant patients with cardiac disease delivering at Groote Schuur 
Hospital was initiated to allow the acquisition of South African data.  
 
Patients attending a dedicated multidisciplinary clinic were given counseling and had 





This study was designed to assess perinatal outcome in babies born to South African 
mothers with cardiac disease who attended this multidisciplinary clinic at Groote 






1. To describe the perinatal outcome of pregnancies in women with heart 
disease. 
2.  To compare the perinatal mortality rate to the perinatal mortality rate for 
the background population during the study period.  
3. To determine whether there are any other associated adverse outcomes in 








This study was a prospective data analysis from 1 July 2010 to 31 Dec 2012.  
 
Participants 
Pregnant women with cardiac disease referred to the combined cardiology and 
obstetric clinic at Groote Schuur Hospital, Western Cape, South Africa were recruited 
consecutively, starting on the 1 July 2010. All women attending the clinic had either 
known cardiac disease or suspected cardiac disease. The diagnosis was confirmed 
or excluded at the first clinic appointment and those with confirmed cardiac disease 
were included in the study. Referrals to this clinic were accepted from all districts in 
South Africa. However most patients were resident in the Cape Town area and 
attended Groote Schuur Maternity Unit. The clinic aimed, to optimize care and 
provide the necessary support and counseling, as well as to correctly diagnose 
suspected cardiac disease, or congenital lesions where the diagnosis was not 




Patients were interviewed and examined by a cardiologist with a special interest in 
pregnancy and heart disease and an obstetrician with a special interest in maternal 
medicine. An echocardiogram was performed on each patient at the first visit.  
 
The primary diagnosis was made or confirmed with additional secondary diagnoses 
noted. The patient’s cardiac condition was classified according to the World Health 
Organization (WHO) classification of heart disease: class I-IV. 
 
The patient was counseled and informed of any potential adverse outcome or likely 
complications in the pregnancy. Appropriate medications were prescribed and 
additional investigations requested if indicated. 
  
Follow up visits were scheduled in the combined clinic as well as the high risk 
antenatal clinic and repeat echocardiograms were performed and medication 
administered or adjusted as required.  
 
Fetal ultrasounds were done at booking, at 13 weeks (if the patient presented early 




pregnancy. The 13-week ultrasound measured the nuchal translucency and 
screened for cardiac and chromosomal disorders and the 20-week scan investigated 
for structural fetal abnormalities. Further scans were requested as indicated, for 
example ultrasound measurement of fetal growth and weight was often indicated at 
28-34 weeks.  
 
Patients delivered at the Groote Schuur Maternity unit. Standard obstetric practices 
applied and additional interventions or monitoring were provided if indicated 
depending on the nature of the cardiac disease. Spontaneous labour progressing to 
a vaginal delivery was preferred and caesarean sections were performed for 
obstetric indications. In the case of certain cardiac lesions an operative delivery was 
deemed preferable, in which case the patient was counseled accordingly.  
 
Additional cardiac and/or invasive monitoring was offered in the Intensive Care Unit 
of the Maternity Center when indicated. 
 
Postnatal follow up appointments were scheduled for 6 weeks after delivery except in 
cases where closer follow up was indicated. 
 
Definitions 
Adverse neonatal outcome was defined as stillbirth, early neonatal death, admission 
to Neonatal Intensive Care Unit (NICU) or the requirement for delivery room 
resuscitation.  
 
Neonatal intervention was defined as resuscitation at birth, and or admission to 
NICU. 
 
Gestational age at term was defined as a delivery at 37-completed week (38 weeks) 
or beyond.  
 
Preterm delivery was defined as delivery before 37 completed weeks gestation, and 
very preterm delivery was defined as delivery before 33 completed weeks gestation 
(34 weeks). 
 
Normal birth weight was defined as an infant birth weight of between 2500 grams 




2500 grams. Very low birth weight was defined as an infant birth weight of less than 
1500 grams. 
 
Intrauterine growth restriction was diagnosed after delivery using standard centile 
charts by the neonatologists. A fetus could have had both low birth weight and 
growth restriction.  
 
 Maternal cardiac disease was classified according to World Health Organization 








Table 2: World Health Organization Classification of Cardiac Diseases  
Conditions in which pregnancy risk is WHO I 
Uncomplicated small or mild 
-Pulmonary stenosis 
-Patent ductus arteriosus 
-Mitral valve prolapse 
Successfully repaired simple lesions (arterial or ventricular septal defect, patent ductus 
arteriosus, anomalous pulmonary venous drainage)  
Arterial or ventricular ectopic beats, isolated 
Conditions in which pregnancy risk is WHO II or III 
WHO II (if otherwise well and uncomplicated)  
Unoperated atrial or ventricular septal defect 
Repaired tetralogy of Fallot 
Most arrhythmias 
WHO II-III (depending on individual)  
Mild left ventricular impairment 
Hypertrophic cardiomyopathy 
Native or tissue valvular heart disease not considered WHO I or IV 
Marfan syndrome without aortic dilatation 
Aorta < 45mm in aortic disease associated with a bicuspid valve 
Repaired Coarctation 
WHO III 
Mechanical valve  
Systemic right ventricle 
Fontan circulation 
Cyanotic heart disease (unrepaired)  
Other complex congenital heart disease  
Aortic dilatation 40-45mm in Marfan syndrome  
Aortic dilatation 45-50mm in aortic dissection with bicuspid aortic valve 
Conditions in which pregnancy risk is WHO IV (Pregnancy contraindicated)  
Pulmonary arterial hypertension of any cause 
Severe systemic ventricular dysfunction (LVEF<30%, NYHA III-IV)  
Previous peripartum cardiomyopathy with any residual impairment of left ventricular function 
Severe mitral stenosis, severe symptomatic aortic stenosis  
Marfan syndrome with aorta dilated >45mm 
Aortic dilatation >50mm in aortic disease associated with bicuspid aortic valve 







All patients consented to have information entered anonymously on a database. 
Information was recorded on hard copies and transposed into a spreadsheet on a 
password-protected computer. The entry of the maternal data was made after each 
visit. The data pertaining to the neonate was extracted at the postnatal follow- up visit 
or via a folder audit. In cases where the folders could not be located or the patients 
did not attend the postnatal visit, information was obtained by telephone.  
 
Ethics Approval 
Ethical approval was obtained from the University Ethical Committee. Reference 
number HREC 173/2010. 
 
Data Analysis  
Descriptive data were generated comparing adverse perinatal outcome with maternal 






Eighty-two patients were included in the study. 
 
Maternal diagnoses  
Maternal diagnoses included all forms of congenital and acquired cardiac disease. 
The distribution of diagnoses is listed in Table 3 and maternal demographic details 
described in the text and Tables 4 which follows.  
 
Table 3: Maternal primary diagnosis 
Cardiac Disease  Total  Number  Percentage 
Congenital Heart Disease 28  34 
Uncomplicated/repaired VSD/ASD  7 8.5 
VSD/ASD with additional abnormality  7 8.5 
Congenital valvular heart disease  3 3.6 
Coarctation of Aorta     4 4.8 
Transposition of Great Arteries   1 1.2 
Tetralogy of Fallot     3 3.6 
Coronary/Pulmonary artery malformation  3 3.6 
Valvular Heart Disease  25  30 
Rheumatic Valvular Heart Disease   18 21.9 
 Replaced Valves    
Mechanical  6 7.3 
Bioprosthesis  1 1.2 
Left Ventricular Dysfunction     
Cardiomyopathy   19  23 
HIV  2 2.4 
Peripartum     7 8.5 
Hereditary     2 2.4 
Dilated     2 2.4 
PET/HT  6 7.3 
Other 10  12 
Arrhythmias   6 7.3 
Marfan Syndrome    1 1.2 
IHD      1 1.2 
Takayasus      1 1.2 
Portal vein thrombosis    1 1.2 
VSD=ventricular septal defect; ASD=atrial septal defect; HIV=human immunodeficiency virus 




Maternal demographics  
 
Table 4: Maternal demographics  
 Average Range 
Age (Years) 27 15-43 
BMI (kg/m2) 27 15-44 
 
Age 
The average maternal age was twenty-seven years. The oldest was forty-three years 
old and the youngest fifteen years old.  
 
Parity 
The median parity was one. Thirty patients (36%) had two or more children.  
 
Gestational age at booking   
The average gestational age at booking was at sixteen weeks. Three patients were 
unbooked, and one patient presented at the booking clinic acutely unwell at twenty-
eight weeks.  
 
Body habitus  
The average BMI was 27kg/m2 .The BMI of seven women had not been recorded. 
The highest BMI recorded was 44kg/m2.  
 
WHO class IV cardiac disease  
A total of twenty-three patients had cardiac disease classified by the World Health 
Organization (WHO) as class IV disease.  
 
Twenty-one of the twenty-three patients with WHO class IV disease booked their 
pregnancies. The average gestational age at booking in these twenty-three patients 
was sixteen weeks. Six out of the twenty-three, (26%) class IV cardiac patients 
booked in the first trimester. Two out of the three unbooked patients in this study 





Of the forty-nine multigravida patients, twelve, (24%) had WHO class IV disease. In 
some cases the cardiac disease either presented or was diagnosed in the incident 
pregnancy, however in other cases the diagnosis was known and advice had been 
given to avoid future pregnancies.  
 
Gestational age at delivery  
The average gestational age at delivery was thirty-seven weeks. Of the live born 
neonates (n=78), fifty-five out of seventy-eight were born at term. Thirteen patients 
delivered at or after forty weeks, and forty-two patients delivered at thirty-eight or 
thirty-nine weeks. 
 
One patient suffered a miscarriage at eleven weeks. The most premature delivery 
was at twenty-seven weeks and the neonate weighed 800g. This patient delivered at 
George Hospital.  
 
Termination of pregnancy  
There were two terminations of pregnancy. Both terminations were indicated for fetal 
reasons: a Dandy Walker malformation in one and a congenital cardiac lesion (a 
large VSD) in the other.  
 
Mode of delivery  
There were thirty-three patients delivered by caesarean section and one patient was 
delivered by hysterotomy. This represents an operative delivery rate of forty-one 
percent. The caesarean sections and the indications for operative delivery are listed 
in Table 5. Table 6 lists the cardiac indications for emergency and elective caesarean 
sections. 
 
Table 5: Caesarean section deliveries 
Caesarean Section  Number Indication Number 
Emergency  20 Obstetric 16 
  Cardiac 4 
Elective 14 Obstetric 9 






Table 6: Cardiac indications for Caesarean sections 
Elective CS 
Cardiac Indication 
No. Emergency CS 
Cardiac Indication 
No. 
Pulmonary arteriovenous malformation  1 Mitral valve replacement/sepsis 1 
Repaired Coarctation of aorta  2 Pulmonary edema 1 
Cardiomyopathy  1 Eclampsia CCF and CMO 1 
Mixed mitral valve disease  1 Severe MR and CCF 1 
 
CCF=congestive cardiac failure; CMO=cardiomyopathy MR=mitral regurgitation; 
CS=caesarean section 
 
Ten patients underwent induction of labour (IOL). Of these, seven patients were 
induced for maternal cardiac indications and three were induced for obstetric 
indications.  
 
The seven cardiac indications for induction of labour were based upon deteriorating 
symptoms of dyspnoea in six out of the seven cases. The remaining patient had 
labour induced electively during working hours because she had an arrhythmia for 
which intra-partum external cardiac pacing may have been necessary. The induction 
was timed to allow access to all cardiac and critical care facilities.  
 
For the patients who had an induction of labour based upon worsening dyspnoea, 
one patient presented at George Hospital at term with pulmonary edema. Labour 
was induced because of persistent heart failure despite medical treatment. A 
subsequent diagnosis of peripartum cardiomyopathy was made (Table 7).  
 
The three patients who were induced for obstetric indications delivered three healthy 
neonates.  
 
Table 7: Maternal cardiac indications for IOL  
Cardiac Indication Number 
Worsening dyspnoea 6 






Neonatal data  
 
Perinatal outcome 
There was one miscarriage, one stillbirth, no early neonatal deaths and one neonatal 
death. The perinatal mortality rate for this study group was 1/82, equating to 12.1 
deaths per 1000 live births. 
The still birth and neonatal death are described in Appendix A.  
 
Seven babies met the criteria for neonatal intervention as defined by the study 
protocol (resuscitation at birth, and or admission to NICU).  
 
The composite adverse outcome (as defined as perinatal mortality, resuscitation at 
birth and admission to NICU) was eight out of eighty-two babies (9.7%) 
 
Need for delivery room resuscitation  
Thirteen neonates required some form of resuscitation at birth (Table 8). Twelve 
infants were resuscitated using a neonatal facemask and ambubag and one infant 
required intubation and ventilation. Of these, four had low five-minute Apgar scores.  
 
One infant was born at George Hospital and the details of the neonatal condition at 
birth were not known.  
 
Of these thirteen babies, six were healthy and required no further paediatric care. 
These six were thus excluded as little intervention in the delivery room was required, 
they had no evidence of asphyxia, and did not require admission to NICU. Three 
neonates had respiratory distress syndrome and three had a diagnosis of “birth 
asphyxia” (Table 8). One infant succumbed to complications of prematurity (neonatal 
death described in Appendix A).  
 
Clinically diagnosed asphyxia neonatorum 
There were three neonates with the diagnosis of birth asphyxia. (Table 8) The details 




















35 Yes MR/ pulm 
edema/PET 
2530 9 7.2 Boarder Healthy 
38 No Marfan 2480 9 NG No Healthy 
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VSD=ventricular septal defect; PS= pulmonary stenosis; pulm=pulmonary; MR=mitral 
regurgitation; MMVD=mixed mitral valve disease; MVR= mitral valve replacement 
Diap=diaphragmatic hernia; PET=Preeclampsia; HT= hypertension; PDA=persistent ductus 
arteriosus; CoA= Coarctation of aorta; CMO=cardiomyopathy; PPCMO=peripartum 
cardiomyopathy 
 
Admission to Neonatal Intensive Care Unit (NICU) 
Seven infants required admission to NICU. Four babies admitted to NICU directly 




analysis (pH<7.2) (Table 8) and two were admitted with good Apgar scores and cord 
pH values, but required intensive care for sepsis (urinary tract infection and 
pneumonia) and one baby was delivered at George Hospital with extreme 
prematurity at twenty-seven weeks weighing 800g and remained in NICU at George 
Hospital. 
 
Two cases of adverse neonatal outcome (admission to NICU for sepsis) developed 
independently of any pregnancy or maternal-related factors and have not been 
included in this analysis 
 
Twenty-six other babies were kept in the nursery. Fifteen were admitted for neonatal 
observation, one for blood glucose level monitoring and ten healthy infants were 
cared for in the nursery, as the mothers were too unwell to nurse them.  All of these 
babies had a normal outcome.  
 
Obstetric risk factors associated with adverse neonatal outcome 
Of the eight cases in which adverse neonatal outcome occurred (including perinatal 
mortality, the need for delivery room resuscitation or NICU admission) described 
above, seven mothers suffered from one or more of the obstetric risk factors listed in 
Table 9. One mother had no additional obstetric risk factors. Of the seven mothers 
with obstetric risk factors, the neonatal outcome was influenced by the obstetric 
complication in four cases (Figure 1). 
 
Table 9: Neonatal adverse outcome and associated obstetric risk factors in the 
17 pregnancies with adverse neonatal outcome 
 
ORF No. of mothers 
affected 
No. of neonates with 
NAO secondary to ORF 
NAO associated 
ORF 
HIV 3 none  
BMI >25  0 none  
BMI > 30  2 none  
PET 2 2 Resuscitation 
NICU 
DM 1 1 Resuscitation 
Medical conditions 1 none  
Placenta praevia 1 2 Resuscitation 
Total   4  
 
ORF=obstetric risk factor, NAO= neonatal adverse outcome, PTD= preterm delivery (before 








In a total of four out of the eight cases (50%), there was either no obstetric risk factor 
or the obstetric complication had no influence on the adverse neonatal outcome.   
 
Intrauterine growth restriction  
Two neonates were diagnosed to be growth restricted. The details of these babies 
can be found in Appendix C.  
 
Preterm delivery  
Twenty-four patients delivered before thirty-eight weeks (29%). This group includes 
the NND, SB and intrauterine growth restriction babies described previously.  
 
Of these twenty-four patients, fourteen mothers went into spontaneous preterm 
labour. Of these fourteen, four mothers had worsening cardiac disease at the onset 
of labour (mitral valve replacement and sepsis in two mothers, cardiomyopathy and 
pulmonary edema in one patient and coarctation of the aorta with aortic valve 
replacement in one patient).  
The remaining ten patients were well at the onset of preterm labour.  
Two patients were delivered preterm electively because of cardiac disease. 
 
Obstetric risk 
factors in the 8 
casese of adverse 















Obstetric intervention  
 
Induction of labour for cardiac indications and adverse neonatal outcome 
Of the seven patients induced for cardiac indications, four of the infants were healthy, 
(all term vaginal deliveries) (Table 10). The three neonates who suffered 
complications have been described previously (IUGR, PTD, HIE)  
 
 
Table 10: Indications and outcome for those patients delivered for cardiac 
indications following IOL  
 








38 IOL NVD 2800 9 Healthy 
Cardiomyopathy  40 IOL NVD 2870 10 Healthy 
Cardiomyopathy  38 IOL NVD 3700 9 Healthy 
Cardiac arrhythmia  38 IOL NVD 3375 9 Healthy 
Maternal CCF  35 IOL NVD 2075 8 LBW/IUGR 
Pulmonary Edema  35 IOL CS 2530 9 PTD 
Worsening maternal 
cardiac failure  







Delivery by Caesarean Section for cardiac indications and adverse neonatal 
outcome 
Of the patients delivered by caesarean section for cardiac indications, (n=9), three 
neonates were healthy. Two delivered preterm but were healthy. There was one 
stillbirth and one neonatal death (described previously). Details of the adverse 
neonatal outcome in these deliveries are reflected in Table 11. 
 
 
Table 11: Indications and Outcome in those patients delivered for cardiac 
indication. CS  
 






Repaired Coarctation of 
aorta  
38 CS (el) CS 3090 10 Healthy 
Repaired Coarctation of 
aorta  
39 CS (el) CS 2750 9 Healthy 
Mixed mitral valve 
disease  
39 CS (el) CS 2960 9 Healthy 
Pulmonary AV 
malformation  
37 CS (el) CS 2360 9 PTD/LBW 
(Healthy) 
Maternal det  36 CS (em) CS 3450 10 PTD (Healthy) 
Mitral valve 
replacement/sepsis  
37 CS (em) CS 2280 7 PTD/LBW/ 
Sepsis/RDS 
Pulmonary edema  30 CS (em) CS 1230 7 PTD/LBW/Asp
hyxia/RDS/NN
J 
Pre-Eclampsia CCF and 
CMO  
34 CS (em) CS 1725 9 PTD/IUGR 
Cardiomyopathy  35 CS (el) CS 2234 0 SB/PTD/LBW 
 
 
Neonates born at Term  
Of those neonates who were born at term, twenty-four women required antenatal 
intervention, which allowed the pregnancy to continue. In most cases, this involved 
the administration of either a diuretic or β-Blockers or both with increased outpatient 







Congenital cardiac disease in the fetus 
The rate of congenital heart disease in the fetus was 3/82 (36%). The stillborn baby 
had a multiple fetal anomalies including a cardiac lesion, one pregnancy was 
terminated for Aortic override and a large VSD in the fetus and the baby who passed 
away at one month of age had a persistent PDA related to prematurity. In all three of 







This database describes a unique African program of health care. The combined 
cardiac and obstetric clinic provided patients with good access to a multidisciplinary 
team, a reliable triage and referral system and access to neonatal intensive care.  
 
The perinatal outcome (expressed as perinatal mortality) was good. The literature 
has described an association between maternal cardiac disease and perinatal 
mortality, which was not evident in this study. The perinatal mortality rates were in 
the same order as the general perinatal mortality rates in industrialized countries.  
 
The Perinatal Mortality Rate in this cohort was also below the rate for the general 
population from whence this cohort came. (Perinatal mortality rate for the Metro West 
is 28.8 per 1000 for the study period). The rate was also below the national rate 
reported for South Africa. (The perinatal mortality rate for South Africa during 2010 
was 34/1000). The perinatal mortality rate for this study cohort is better than that 
reported for Africa in published literature, (7.6%) and is more in keeping with 
industrialized countries (1-4%). In addition, one case of a stillborn infant occurred in a 
child with multiple anomalies and there was no connection with maternal cardiac 
disease.  
 
Nine percent (8/82) of the neonates in this audit had suffered adverse outcome 
(perinatal mortality, delivery room resuscitation or admission to NICU). This is lower 
than similar rates described in industrialized countries. (Sui et al reports a rate of 17-
28%) The rate of obstetric intervention, (operative delivery and PTD), was similarly 
high, but can be ascribed to factors other than cardiac disease. In 50% of cases of 
adverse neonatal outcome, additional obstetric risk factors necessitated obstetric 
intervention and therefore influenced the neonatal outcome.  
 
These data are nevertheless too few to allow firm conclusions regarding the 
influence of maternal cardiac disease on obstetric intervention and outcome.  
 
Preterm delivery is recognized as a major contributing factor to adverse perinatal 
outcome. In this study, the average gestational age was 37 weeks, and 29% of 
patients delivered preterm. Although this rate of preterm delivery exceeded the 




adverse neonatal outcome (perinatal mortality, delivery room resuscitation or 
admission to NICU).  
 
When the data are examined from the perspective of cardiac disease, 7 patients 
required obstetric intervention (induction of labour). Three babies suffered 
complications partly due to maternal cardiac disease. One baby developed HIE as a 
consequence of delivering in transit, (an unmonitored and uncontrolled delivery in the 
air ambulance). The other infant with birth asphyxia was delivered after the mother 
had labour induced because of pulmonary edema and preeclampsia at 35 weeks. 
She had severe mitral regurgitation and had been on a diuretic antenatally. The pre-
eclampsia may have contributed to the development of pulmonary edema because of 
left ventricular diastolic dysfunction. This baby had a cord pH of 7.2, and did not 
require neonatal intensive care. The third had intrauterine growth restriction. This 
mother had an HIV-related cardiomyopathy and was admitted for a prolonged time 
antenatally. She was treated with a diuretic, antihypertensive agent and digoxin.  She 
had severe decline in cardiac function in the pregnancy. The baby was healthy and 
did not require admission to the NICU.  
 
Of the 9 babies born for cardiac indications by caesarean section, three of the 
remaining 4 babies who had neonatal complications did have maternal cardiac 
disease that may have contributed to the subsequent outcome (that of the mitral 
valve replacement and sepsis and cardiomyopathy delivered at 33 weeks and the 
delivery at 30 weeks for preeclampsia and pulmonary edema).  
 
In summary, in all categories of cardiac disease in which obstetric intervention was 
considered necessary, there was only one seriously affected child, namely the baby 
born in the air ambulance, where the circumstances of obstetric care were probably 
more responsible for the subsequent outcome than the underlying maternal condition 
itself.  
 
When the data is analyzed according to the different categories of cardiac disease, 
the distribution was evenly distributed between congenital heart disease and 
rheumatic fever, as well as a much smaller group of other diagnoses.  
 
The maternal congenital heart disease had no effect on the perinatal outcome. Of the 
babies delivered to mothers with congenital heart disease who had adverse neonatal 




sepsis requiring readmission NICU and spontaneous preterm labour resulting in the 
need for delivery room resuscitation.  
 
In the rheumatic heart disease group, the majority of cases, the maternal cardiac 
disease had no influence on the perinatal outcome. In only three cases from this 
group where adverse neonatal outcome was documented, could the maternal 
cardiac disease have had a direct effect on this outcome.  
 
The rate of neonatal congenital heart disease was 3/82 (36%), which is higher than 
recorded in the literature and influenced the rate of adverse outcome. Not one of 
these three cases was inherited cardiac disease, as in all three cases the maternal 
cardiac disease was acquired. 
 
The data also shows that women with severe disease present in pregnancy, and 
book at a late gestation, despite previous advice to avoid pregnancy. Despite the 
presence of WHO IV disease, no mothers decided to terminate on the basis of 
maternal cardiac disease alone. The inability to reproduce has significant social 
implications in the South African setting and consent to a medically indicated 








The perinatal mortality is better than that quoted in the literature, and better than the 
rate for the service as a whole, however there was a high rate of obstetric 
intervention noted in this study group. The complication rate for adverse neonatal 
outcome is better than the rate cited in the literature for industrialized countries, 
although prematurity rates were high. Obstetric risk factors influenced the rate of 
adverse neonatal outcome in 50% of cases.  
 
Neonatal outcome is improved when mothers with heart disease are managed in a 
multidisciplinary clinic, but this sample size is small and continuous data collection 
and analysis would be helpful in assessing the degree of surveillance required in 
pregnancies complicated by maternal heart disease to allow the best outcome for 
















Stillbirth and neonatal death 
The stillborn infant was born to a mother with HIV-related cardiomyopathy (CMO). 
She booked at 15 weeks. An echo revealed an ejection fraction of 54% with diastolic 
dysfunction. Her CD4 count was 242 and she was taking antiretroviral treatment and 
had a suppressed viral load at the time of delivery. A renal biopsy prior to pregnancy 
had shown HIVAN (HIV associated nephropathy). Her BMI was 21kg/m2 and she 
was not diabetic. The CMO was managed with a diuretic and a β-blocker. Multiple 
fetal anomalies were diagnosed in the fetus (Hydrocephalus, cardiac lesion and 
macrocephaly amongst others). This patient declined a termination of pregnancy. 
The caesarean delivery was indicated for macrocephaly. The post mortem described 
multiple anomalies, attributable to any specific syndrome.  
 
One infant died at 1 month of age. This mother delivered at 34 weeks because she 
had a major placenta praevia. The mother was 37 years old and had two children. 
She booked at 12 weeks. She had severe mitral regurgitation (WHO III) leading to an 
episode of cardiac failure during the antenatal period. She required treatment with a 
diuretic and spironolactone, despite an ejection fraction of 57%. She also suffered 
from diabetes mellitus and was on insulin for the duration of the pregnancy. The 
mother was admitted for a total of 40 days prior to delivery and required intubation for 
the caesarean section. The infant weighed 1800 grams and required resuscitation 
with bag-mask ventilation due to respiratory stress syndrome. The five-minute Apgar 
score was 9/10. However, the baby required admission to the NICU. The neonate 
suffered the following complications associated with prematurity: persistent PDA, 
intraventricular haemorrhage, sepsis, persistent acidosis, necrotizing enterocolitis 





APPENDIX B  
 
Cases of clinically diagnosed asphyxia neonatorum 
There were three babies with birth asphyxia. One infant suffered hypoxic ischemic 
encephalopathy (HIE). This baby was delivered vaginally at 40 weeks and weighed 
2880 grams. The baby delivered in the air ambulance on route to Groote Schuur 
Hospital because labour had been induced at George Hospital prior to transportation. 
The Apgar score at 5 minutes was 1/10 and the neonate was intubated and 
ventilated before admission to the neonatal intensive care unit (NICU). 
 
The second infant was born at 30 weeks by emergency CS weighing 1230 grams. 
This mother had severe preeclampsia and pulmonary edema. She was admitted for 
3 days prior to delivery for stabilization, and required admission to the intensive care 
unit (ICU).  She had an ejection fraction of 39%. The pulmonary edema was 
attributed to preeclampsia, rather than an underlying cardiac lesion. This mother 
recovered normal cardiac function postpartum (postpartum ejection fraction of 55%). 
This preterm infant had a 5 minute Apgar score of 7/10, and a cord blood gas of 
7.18. The baby subsequently developed  septicemia, RDS and neonatal jaundice 
(NNJ) requiring admission to the NICU, although intubation was not required. This 
infant was discharged at 1 month old.    
 
The third infant was delivered at 40 weeks and weighed 3125 grams. The mother 
had eclampsia, abruptio placentae and a peripartum cardiomyopathy, diagnosed on 
the basis of reduced ejection fraction, measured during the puerperium. This neonate 
was born by emergency caesarean section. Chest compressions and ventilatory 
support via a neonatal facemask and ambubag were required and the infant 






APPENDIX C  
Intrauterine growth restriction 
One infant was born at 35 weeks. This mother had an HIV-related cardiomyopathy 
and preexisting hypertension. Her ejection fraction was 24%. She was placed on a 
diuretic, digoxin and antihypertensive medication antenatally. She was not treated 
with β-blockers.  She was admitted for 37 days prior to delivery. She had two 
episodes of cardiac failure at 32 and 35 weeks and labour was induced at 35 weeks. 
The infant weighed 2075 grams.  
 
The second neonate was delivered at 34 weeks because the mother developed 
preeclampsia. This infant weighed 1725 grams and was admitted to the nursery. 
There were signs of intrauterine growth restriction. In addition to preeclampsia, this 
mother had a dilated cardiomyopathy, developing congestive cardiac failure at 33 
weeks. Deteriorating renal function developed as a complication of the pre-
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